138 related articles for article (PubMed ID: 18700961)
1. Cost effectiveness of chest pain unit care in the NHS.
Oluboyede Y; Goodacre S; Wailoo A;
BMC Health Serv Res; 2008 Aug; 8():174. PubMed ID: 18700961
[TBL] [Abstract][Full Text] [Related]
2. Is a chest pain observation unit likely to be cost saving in a British hospital?
Goodacre S; Morris F; Arnold J; Angelini K
Emerg Med J; 2001 Jan; 18(1):11-4. PubMed ID: 11310454
[TBL] [Abstract][Full Text] [Related]
3. Randomised controlled trial and economic evaluation of a chest pain observation unit compared with routine care.
Goodacre S; Nicholl J; Dixon S; Cross E; Angelini K; Arnold J; Revill S; Locker T; Capewell SJ; Quinney D; Campbell S; Morris F
BMJ; 2004 Jan; 328(7434):254. PubMed ID: 14724129
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of point-of-care biomarker assessment for suspected myocardial infarction: the randomized assessment of treatment using panel Assay of cardiac markers (RATPAC) trial.
Fitzgerald P; Goodacre SW; Cross E; Dixon S
Acad Emerg Med; 2011 May; 18(5):488-95. PubMed ID: 21569168
[TBL] [Abstract][Full Text] [Related]
5. Is a chest pain observation unit likely to be cost effective at my hospital? Extrapolation of data from a randomised controlled trial.
Goodacre S; Dixon S
Emerg Med J; 2005 Jun; 22(6):418-22. PubMed ID: 15911949
[TBL] [Abstract][Full Text] [Related]
6. Patient satisfaction with chest pain unit care: findings from the Effectiveness and Safety of Chest Pain Assessment to Prevent Emergency Admissions (ESCAPE) cluster randomised trial.
Cross E; Goodacre S;
Emerg Med J; 2010 Oct; 27(10):774-8. PubMed ID: 20659879
[TBL] [Abstract][Full Text] [Related]
7. A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1.
Connock M; Juarez-Garcia A; Frew E; Mans A; Dretzke J; Fry-Smith A; Moore D
Health Technol Assess; 2006 Jun; 10(20):iii-iv, ix-113. PubMed ID: 16729919
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of the clinical effectiveness and cost-effectiveness and economic modelling of minimal incision total hip replacement approaches in the management of arthritic disease of the hip.
de Verteuil R; Imamura M; Zhu S; Glazener C; Fraser C; Munro N; Hutchison J; Grant A; Coyle D; Coyle K; Vale L
Health Technol Assess; 2008 Jun; 12(26):iii-iv, ix-223. PubMed ID: 18513467
[TBL] [Abstract][Full Text] [Related]
9. The cost-effectiveness of testing for hepatitis C in former injecting drug users.
Castelnuovo E; Thompson-Coon J; Pitt M; Cramp M; Siebert U; Price A; Stein K
Health Technol Assess; 2006 Sep; 10(32):iii-iv, ix-xii, 1-93. PubMed ID: 16948891
[TBL] [Abstract][Full Text] [Related]
10. Cost effectiveness of diagnostic strategies for patients with acute, undifferentiated chest pain.
Goodacre S; Calvert N
Emerg Med J; 2003 Sep; 20(5):429-33. PubMed ID: 12954681
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
12. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
[TBL] [Abstract][Full Text] [Related]
13. Sixty-four-slice computed tomography of the coronary arteries: cost-effectiveness analysis of patients presenting to the emergency department with low-risk chest pain.
Khare RK; Courtney DM; Powell ES; Venkatesh AK; Lee TA
Acad Emerg Med; 2008 Jul; 15(7):623-32. PubMed ID: 19086322
[TBL] [Abstract][Full Text] [Related]
14. Cost-utility analysis of physiotherapy treatment compared with physiotherapy advice in low back pain.
Rivero-Arias O; Gray A; Frost H; Lamb SE; Stewart-Brown S
Spine (Phila Pa 1976); 2006 May; 31(12):1381-7. PubMed ID: 16721304
[TBL] [Abstract][Full Text] [Related]
15. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
16. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of alternative strategies for the initial medical management of non-ST elevation acute coronary syndrome: systematic review and decision-analytical modelling.
Robinson M; Palmer S; Sculpher M; Philips Z; Ginnelly L; Bowens A; Golder S; Alfakih K; Bakhai A; Packham C; Cooper N; Abrams K; Eastwood A; Pearman A; Flather M; Gray D; Hall A
Health Technol Assess; 2005 Jul; 9(27):iii-iv, ix-xi, 1-158. PubMed ID: 16022802
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic surgery for inguinal hernia repair: systematic review of effectiveness and economic evaluation.
McCormack K; Wake B; Perez J; Fraser C; Cook J; McIntosh E; Vale L; Grant A
Health Technol Assess; 2005 Apr; 9(14):1-203, iii-iv. PubMed ID: 15842951
[TBL] [Abstract][Full Text] [Related]
19. The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.
Loveman E; Green C; Kirby J; Takeda A; Picot J; Payne E; Clegg A
Health Technol Assess; 2006 Jan; 10(1):iii-iv, ix-xi, 1-160. PubMed ID: 16409879
[TBL] [Abstract][Full Text] [Related]
20. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
